To compare intravenous magnesium sulfate to oral nifedipine for acute tocolysis of preterm...
Date First Received: September 12, 2005
Last Updated: May 9, 2008
Verified by: Stanford University, May 2008
Clinical Trial Phase: N/A | Start Date:
Overall Status: Completed
Estimated Enrollment: 0
Brief Summary
Condition Keyword(s):
Intervention(s):
To compare intravenous magnesium sulfate to oral nifedipine for acute tocolysis of preterm labor
Study Type: Interventional
Study Design: Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: stopping preterm labor
- Drug: Nifedipine or Magnesium Sulfate
Outcome Measures for this Clinical Trial
Primary Measures
- No delivery in 48 hours and uterine quiescence
Criteria for Participation in this Clinical Trial
- Inclusion Criteria::- Uterine contractions and cervical change or ruptured membranes in a preterm gestation Exclusion Criteria:- placental abruption, fetal distress, placenta previa, maternal medical contraindication to tocolysis
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Stanford University
Overall Clinical Trial Officials and Contacts
Yasser Yehia El-Sayed Principal Investigator Stanford University
Additional Information
Information obtained from ClinicalTrials.gov on August 29, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00185900
Study ID Number: 76145
ClinicalTrials.gov Identifier: NCT00185900
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
